Corporate Engagements

The IOA is engaging the following companies on their policies and practices pertaining to opioids:

 

OPIOID MANUFACTURERS:

Johnson & Johnson (JNJ) (separate Chair & CEO)

Mallinckrodt (MNK) (financial & reputational risks related to the opioid crisis)

Mylan (MYL)

Depomed (DEPO) Read the Depomed exempt solicitation here

Endo (ENDP)

Insys (INSY)

 

TREATMENT & ADDICTION DRUG MANUFACTURERS:

Mylan (MYL)

Amphastar (AMPH)

Indivior (INDV)

Pfizer (PFE) (separate Chair & CEO) Read the Pfizer exempt solicitation here.

Alkermes (ALKS)

 

DISTRIBUTORS:

McKesson (MCK) (lobbying expenditures)

Cardinal Health (CAH) 

AmerisourceBergen (ABC) (financial & reputational risks related to the opioid crisis + executive incentive pay clawback)

Sign Up for our eNewsletter

* indicates required